Infants face a meningitis risk nearly 17 times higher than the general population in Belgium, according to data released for World Meningitis Day. The Belgian Academy of Pediatrics reported that the incidence rate among children under one year old reached 10.9 cases per 100,000 infants in 2024, compared to roughly 0.65 cases per 100,000 residents overall.
Meningococcal Incidence Rates Among Infants Versus the General Population
The stark contrast in infection rates highlights why medical professionals focus heavily on the youngest age group. While the broader population sees less than one case per 100,000 people annually, infants under twelve months old experience a concentration of bacterial threat that can escalate within hours.
According to surveillance data compiled by Sciensano, which houses the National Reference Centre for Neisseria meningitidis, the National Reference Centre confirmed the diagnosis in 77 cases in 2024 and 72 cases in 2025 through laboratory analysis. Last year’s figures included 12 cases involving children under five years of age. Across the country, officials recorded six deaths in 2024 among adolescents and adults, split evenly between serogroup B and serogroup W strains. Death certificate data covering 2014 through 2022 shows between two and nine fatalities each year from invasive meningococcal disease, though experts note actual totals likely run higher due to missed sampling or underreporting.
Early symptoms in infants often prove difficult to identify
The primary danger of invasive meningococcal infections lies in how quickly symptoms deteriorate. The Belgian Academy of Pediatrics warns that early signs are frequently difficult for parents to identify in babies and toddlers.
Recognizable behavioral shifts include unusual sleepiness, sudden irritability, a decrease in feeding, vomiting, or a general decline in physical condition. Because the bacteria can trigger severe complications such as meningitis or septicemia, health authorities treat these infections as acute medical emergencies. The Sciensano website stresses that any suspected case requires mandatory notification to a medical inspector due to high mortality rates and transmission risks.
Belgium offers free quadrivalent vaccines for specific strains
Preventative measures in Belgium center on established immunization programs, though coverage varies by bacterial strain. Regional vaccination schedules in both Flanders and the Fédération Wallonie-Bruxelles have incorporated a quadrivalent vaccine targeting serogroups A, C, W, and Y for several years. Administered around a child’s 15th month, the vaccine is offered free of charge to parents, though it remains non-compulsory.
A separate vaccine exists for meningitis caused by serogroup B, but the Superior Health Council does not currently recommend its systematic use. Historically, the last major epidemic in Belgium occurred in 2001. Case numbers dropped sharply following the introduction of the serogroup C vaccine, leaving strain B as the most frequently encountered variant today.
Frequently Asked Questions About Meningitis Risks in Belgium
Why are infants more vulnerable to meningococcal infections than adults?
This vulnerability creates an infection rate nearly 17 times higher than that of the general public, as documented by the Belgian Academy of Pediatrics.
What actions should parents take if they suspect symptoms?
Parents who notice unusual drowsiness, intense irritability, feeding difficulties, or vomiting in young children must seek immediate medical attention. Because the infection develops rapidly and carries a high risk of death or lasting disability, prompt medical evaluation is vital.
Which bacterial strains currently cause the most infections in Belgium?
Serogroup B is the strain most frequently encountered in modern clinical surveillance across the country. While historical outbreaks prompted successful vaccination campaigns against serogroup C following a 2001 epidemic, recent fatal cases recorded by Sciensano involved both serogroup B and serogroup W.
Keep reading